product one
Date:2019-07-20 keywords:Jiangsu Prekang Biomedical Technology Co., Ltd. Views:381

普瑞康主要致力于各种干细胞(脐带间充质干细胞、脂肪干细胞、胎盘干细胞、羊膜干细胞、乳牙干细胞等)标准化制备,开展干细胞临床研究,申报干细胞新药。目前正在积极推进“脐带间充质干细胞治疗失代偿期乙肝肝硬化”和“脐带间充质干细胞联合生物材料治疗退行性膝关节炎”的临床研究工作,相应动物实验和临床研究正在快速推进中 Prican is committed to the standardized preparation of various stem cells (umbilical cord mesenchymal stem cells, adipose stem cells, placental stem cells, amniotic membrane stem cells, deciduous teeth stem cells, etc.).Develop stem cell clinical research and declare new stem cell drugs. At present, we are actively promoting the co-generation of umbilical cord mesenchymal stem cells and umbilical cord mesenchymal stem cells in the treatment of decompensated hepatitis B cirrhosis.The clinical research of material for the treatment of degenerative knee arthritis is progressing rapidly.普瑞康主要致力于各种干细胞(脐带间充质干细胞、脂肪干细胞、胎盘干细胞、羊膜干细胞、乳牙干细胞等)标准化制备,开展干细胞临床研究,申报干细胞新药。目前正在积极推进“脐带间充质干细胞治疗失代偿期乙肝肝硬化”和“脐带间充质干细胞联合生物材料治疗退行性膝关节炎”的临床研究工作,相应动物实验和临床研究正在快速推进中 Prican is committed to the standardized preparation of various stem cells (umbilical cord mesenchymal stem cells, adipose stem cells, placental stem cells, amniotic membrane stem cells, deciduous teeth stem cells, etc.).Develop stem cell clinical research and declare new stem cell drugs. At present, we are actively promoting the co-generation of umbilical cord mesenchymal stem cells and umbilical cord mesenchymal stem cells in the treatment of decompensated hepatitis B cirrhosis.The clinical research of material for the treatment of degenerative knee arthritis is progressing rapidly.


Jiangsu Prekang Biomedical Technology Co., Ltd.
Address: No. 388 Xinping Street, Suzhou Industrial Park, 23 2F Tengfei Science Park
Zip code: 215000
Contact number: 0512-6788 8231
Email:sunzh@purecell.group
Prican Copyright All Rights Reserved Su ICP No. 18059861-1

Focus on Wechat

Jiangsu Prekang Biomedical Technology Co., Ltd.

Home Tel Contact